but not inorganic selenite altered cdk2 kinase activity in TX 77030, USA asynchronous mouse mammary tumor epithelial cells (4). 1 To whom correspondence should be addressed However, cells in asynchronous cell populations are in different Methylselenocysteine (MSC), an organic selenium comstages of the cell cycle at any given time, thus interpretation pound has significant anticarcinogenic activity against of changes in cell cycle proteins may be imprecise.
Introduction
set was treated with MSC at 50 µM. Cells were collected ( Figure 1 ) after 48 h growth, after 48 h starvation (time 0), and 6, 9, 12, 16 and 24 h after Methylselenocysteine (MSC*) is considered an attractive selenrefeeding with complete medium and subjected to the following assays.
ium compound for chemoprevention based on its organic
Cell cycle analysis nature, low toxicity and substantial anticarcinogenic properties, TM6 cells were plated in 100 mm culture dishes. Following MSC treatment, especially in mammary cells (1, 2) . Earlier work from the cells were enzymatically dissociated and stained with propidium iodide and Thompson's group (3) and our laboratory (4) indicated that examined by flow cytometry (EPICS Profile Analyzer, Coultor Corporation) as MSC inhibits mouse mammary tumor epithelial cell (TM6) described earlier (4) . growth by cellular pathways distinct from those altered by mammary growth remains unexplained. We are approaching (containing 10 mM glucose, 130 mM NaCl, 3 mM KCl, 1 mM Na 2 HPO 4 , 30 this question by examining the effects of selenium on the mM HEPES and 3.3 µM phenol red, pH 7.6) and pulsed with 1 µCi functions of cell cycle regulatory proteins, e.g. cyclins and cdks. DNA replication and mitosis are controlled by the activation ml 20 mM TrisϪHCl, pH 7.5, and 10% TCA solution and finally the of S phase-and M phase-specific cyclin-dependent protein precipitates were dissolved in 0.5 ml 1 N NaOH for 30 min. Each well was counted in a liquid scintillation counter and the data were depicted as kinases (cdks) respectively. The catalytic subunits of these percentage decrease or increase in uptake of radiolabel as compared with the kinases are only active when complexed with their specific untreated control (control was taken as 100% uptake). Each sample was done regulatory subunits, termed cyclins. In mammalian cells S in triplicate.
phase is controlled by cdk2 complexed with S phase cyclins cdk2 sample collection and kinase assay (E and A types) and M phase by cdc2 complexed with M Following treatment with MSC, TM6 cells were lysed in buffer (50 mM phase cyclins (A and B types). Mammalian cells also have TrisϪHCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM EGTA, leupeptin (50 G1-specific cdks and cyclins that promote synthesis of proteins µg/ml), 1 mM NaVO 3 , 1 mM phenylmethylsulfonyl fluoride, (PMSF), aprotinin (25 U/ml), 1 mM NaF and 10 mM β-glycerophosphate) for 15 min on ice. The cell suspensions were then associated and centrifuged at 40 000 r.p.m. *Abbreviations: MSC, methylselenocysteine; DMEM, Dulbecco's modified Eagle's medium; PMSF, phenylmethylsulfonyl fluoride; TBS, Tris-buffered for 1 h at 4°C. Supernatants were measured for their protein content (9). Each sample was pre-cleared and the proteins were immunoprecipitated for the saline; TTBS, Tris-buffered saline plus Tween 20. r.p.m. for 1 h at 4°C. Supernatants were measured for protein content as described above. The lysates were immunoprecipitated with rabbit polyclonal cdk4 (Santa Cruz Biotechnology Inc.) (5 µg/500 µg sample protein) as described above. Recombinant Rb (QED Inc.) was used for the cdk4 kinase assay, following the method described earlier, after modification (11). The bands appearing at 110 kDa were scanned using a Quick Scan densitometer (Helena Laboratories) and the optical densities (integrated intensity in arbitrary units) of the control and MSC-treated samples were compared. The assay was performed twice for all the samples.
Results
Thymidine uptake and cell cycle distribution TM6 cells were grown for 48 h, then starved (no growth factors, no serum) for another 48 h. The cells were released from growth factor deprivation by refeeding them with regular medium. In addition, a second set of cells was treated with MSC at 6 h post-feeding (Figure 2 The results suggest that the majority of MSC-treated cells to reflect the changes in the cdk2 kinase activities. The assay was repeated were arrested in S phase, with a minority never leaving G1 two to four times for all the samples.
phase. In a separate experiment, the cells were also examined not re-enter G1.
was used for determination of total cdk2 proteins, anti-mouse cyclin A
Effect of MSC on cdk2 and cdk4 kinase activity
(monoclonal, 2.5 µg/ml; Oncogene) and anti-human cyclin E (2 µg/ml; UBI Inc.) were added to the blots in 1% milk, 0.1 M TBS, pH 7.5, overnight at The cdk2 kinase activity was represented by the intensity of prior to refeeding (Ϫ48, 0 h) and following synchronization at 6, 9, 12, 16 and 24 h. Cells were washed thrice in 50 mM TrisϪHCl, pH 7.5, followed
Effect of MSC on total cdk2 protein and cyclin A
by lysis in buffer (50 mM HEPES, pH 8.0, 150 mM NaCl, 2.5 mM EGTA, The total cdk2 protein level was high following 48 h uninterrup-1 mM EDTA, 0.1% Tween 20, 1 mM dithiothreitol, 1 mM PMSF, 25 U/ml ted growth, but the levels decreased after starvation (time 0) aprotinin, 10 mM β-glycerophosphate, 1 mM NaVO 3 and 1 mM NaF) for 15 min on ice. The suspensions were sonicated and later centrifuged at 40 000 and were restored in control cells by the 12 h time point. In cdk2 kinase inhibition by methylselenocysteine general, MSC treatment did not change the total cdk2 pool both organic and inorganic, in this process are essentially unknown. Some of the proposed inhibitory mechanisms include over 24 h post treatment ( Figure 5 ). The total cyclin A protein level was high following the initial 48 h uninterrupted growth, interaction with reduced glutathione (12), inhibition of DNA, RNA (13,14) and protein synthesis (15), inhibition of transcripwas low for up to 9 h after refeeding and then increased progressively between 12 and 24 h in control cells. MSC tion factor AP-1 DNA binding (16), thymidine kinase and ribonucleotide reductase enzyme activities (17,18) and inducdecreased cyclin A levels at the 12 (48.6% reduction), 16 (37.9%) and 24 h (35.9%) time points ( Figure 5 ). The total tion of p53 (19). In TM6 cells, however, the last mechanism may not be appropriate, as TM6 cells are mutated for p53. cyclin A represents the free pool of protein as well as protein complexed with cdks.
These analyses have not been performed in synchronized cells, therefore the timing of some of these events with respect to Effect of MSC on cyclin E and A associated with cdk2 DNA synthesis and cell cycle stage have not been elucidated. Cyclin E associated with cdk2 ( Figure 6 ) was decreased at 9 h The use of synchronized cells allows the sequence of events (63.6%) as a consequence of MSC treatment, which correlated to be elucidated and provides information on cause versus with a delay of cells in G1. The cyclin EϪcdk2 level recovered consequence of molecular changes. by 12 h (55.2% increase) in MSC-treated cells, allowing the TM6 cells respond to MSC as efficiently as to selenite when cells to pass the G1/S boundary. At the 16 and 24 h time monitored by [ 3 H]thymidine uptake, but selenite behaves like points MSC caused an insignificant increase in the amounts a cytotoxic agent and possibly inhibits cell growth by a different of cyclin E associated with cdk2 by 7.7 and 7.4% respectively. cellular pathway (3, 4) . Therefore, MSC was investigated in Cyclin AϪcdk2 levels increased slightly as a result of MSC greater detail and an in vitro model for synchronized mouse treatment at the 9 (30.2%) and 12 h time points (35.5%), but mammary epithelial tumor cells (TM6) was used to determine were essentially unchanged at the 16 (10.7% decrease) and the specific effects of MSC during the TM6 cell cycle. 24 h (20.1% decrease) time points ( Figure 6 ).
The starvationϪrefeeding protocol used in these experiments Relation between total cdk2 protein, cdk2 kinase activity and effectively synchronized TM6 cells. Under these conditions, [ 3 
H]thymidine uptake in control and MSC-treated cells
MSC reproduced the specific growth inhibitory effects initially In the present investigation, cdk2 kinase activity was substanobserved in asynchronized TM6 cells (4 Figure 7A ). MSC exerted its intial effect by cells had entered S phase. MSC inhibited [ 3 H]thymidine uptake the 12 h time point (33% reduction). The total cdk2 protein, by Ͼ48%. MSC treatment resulted in a prolonged delay of however, did not change as a consequence of MSC treatment TM6 cells in S phase, as was evident from the FACS analysis ( Figure 7B ), suggesting the possibility that altered phosphoryla-(57% cells in S phase at the 16 h and 56% at the 24 h time tion or association with cyclin inhibitory proteins might be points). MSC-treated cells were arrested or delayed in S phase involved in the decrease in cdk2 kinase activity.
for almost 18 h. The analysis of cdk2 kinase activity was consistent with the FACS analysis. The cdk4 kinase activity Discussion did not change significantly during the cell cycle. Cdk4 kinase activity is associated with D-type cyclins, which function to Selenium is known to inhibit the growth of mammalian cells, regulate transit through the G1 stage. The present data did not but the mechanisms of action of different selenium compounds, show any significant change in cdk4 kinase activity as a result complexed with cdk2 did not change during the cell cycle, thereby suggesting that the increase in total cyclin A protein of MSC treatment, ruling out an arrest of cells in G1. In contrast, cdk2, the major cell cycle regulatory kinase responsible for was either in the free pool or that associated with cdc2. The analysis of cyclins by Western blot indicated that the cell entry and progression through the S phase, exhibited a substantial decrease in kinase activity at 12 and 16 h after cyclin E associated with cdk2 did show a decrease at the 9 h time point as a consequence of MSC treatment. At this time refeeding or 6 and 10 h post MSC treatment.
Cyclins E and A associate with cdk2 and are essential for the cells were in G1. The levels recovered by the 12 h time point, which in turn allowed the cells to successfully pass the its functional activity, along with phosphorylation. The Western blot results show that the total cdk2 protein was constant, G1/S boundary into the S phase. The delay in G1 observed in the MSC-treated cells may be due to the decrease in cyclin while the pool of cyclin A increased starting at 12 h after release from growth arrest. Cyclin A is mainly associated with EϪcdk2 complex, an interpretation supported by another finding (20). cdk2 during S phase but, as the results indicate, the cyclin A When ckd2 was immunoprecipitated and cyclins E and A associated with cdk2 in the cells were analyzed, the immunoblots demonstrated that the amounts of cyclin E bound to cdk2 and cyclin A bound to cdk2 remained constant at the critical 12-16 h time points, indicating that the active pool remained unchanged and that the alteration in cdk2 kinase activity might be due to either altered phosphorylation or the presence of cyclin inhibitors on cdk2, i.e. p15, p21 or p27. There was no It is interesting to note that the MSC-induced decrease in The results suggest the interesting possibility that the effects tion (29) (30) (31) . Future work will focus on PKC being the possible (1996) Human cyclin E, a nuclear protein essential for the G1-to-S phase upstream transduction signal. 
